How to buy The Joint stock
Learn how to easily invest in The Joint stock.
The Joint is a medical care facilities business based in the US. The Joint shares (JYNT) are listed on the NASDAQ and all prices are listed in US Dollars. The Joint employs 359 staff and has a trailing 12-month revenue of around $112.4 million.
How to buy The Joint stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – JYNT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
The Joint stock price (NASDAQ: JYNT)Use our graph to track the performance of JYNT stocks over time.
The Joint shares at a glance
|Latest market close||$9.25|
|52-week range||$8.76 - $20.00|
|50-day moving average||$11.10|
|200-day moving average||$14.33|
|Wall St. target price||$19.88|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.21|
Buy The Joint stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy The Joint stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
The Joint price performance over time
|1 week (2023-09-21)||-3.24%|
|1 month (2023-08-28)||-4.34%|
|3 months (2023-06-28)||-30.50%|
|6 months (2023-03-28)||-42.44%|
|1 year (2022-09-28)||-42.19%|
|2 years (2021-09-28)||-90.86%|
|3 years (2020-09-28)||17.52|
|5 years (2018-09-28)||8.19%|
Is The Joint stock undervalued or overvalued?
Valuing The Joint stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Joint's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Joint's P/E ratio
The Joint's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 44x. In other words, The Joint shares trade at around 44x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
The Joint's EBITDA
The Joint's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $12.3 million.
The EBITDA is a measure of a The Joint's overall financial performance and is widely used to measure a its profitability.
The Joint financials
|Revenue TTM||$112.4 million|
|Operating margin TTM||2.62%|
|Gross profit TTM||$92.1 million|
|Return on assets TTM||1.98%|
|Return on equity TTM||12.73%|
|Market Capitalization||$137.4 million|
TTM: trailing 12 months
The Joint share dividends
We're not expecting The Joint to pay a dividend over the next 12 months.
The Joint share price volatility
Over the last 12 months, The Joint's shares have ranged in value from as little as $8.76 up to $20. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while The Joint's is 1.4416. This would suggest that The Joint's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
The Joint overview
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
The Joint in the news
The Joint Corp. Reports Preliminary Second Quarter 2023 Financial Results
The Joint Corp. Provides Updates on the June 30, 2023 SEC 10-Q Filing
The Joint Corp. to Participate in Upcoming Conferences
Frequently asked questionsWhat percentage of The Joint is owned by insiders or institutions?
Currently 1.371% of The Joint shares are held by insiders and 84.228% by institutions. How many people work for The Joint?
Latest data suggests 359 work at The Joint. When does the fiscal year end for The Joint?
The Joint's fiscal year ends in December. Where is The Joint based?
The Joint's address is: 16767 North Perimeter Drive, Scottsdale, AZ, United States, 85260 What is The Joint's ISIN number?
The Joint's international securities identification number is: US47973J1025 What is The Joint's CUSIP number?
The Joint's Committee on Uniform Securities Identification Procedures number is: 47973J102
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert